Mechanism of action
Amoxicillin is a bactericidal antibiotic that inhibits bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located in the bacterial cell wall, preventing the cross-linking of peptidoglycan chains that provide structural integrity to the cell wall.
Without a functional cell wall, bacteria undergo osmotic lysis and cell death. Amoxicillin is most effective against actively dividing bacteria during the growth phase. The drug has an extended spectrum compared to penicillin G, with improved activity against gram-negative organisms due to better penetration through the outer membrane.
Amoxicillin is susceptible to hydrolysis by beta-lactamase enzymes produced by many bacteria, including most Staphylococcus aureus strains and an increasing proportion of Haemophilus influenzae and Escherichia coli. Co-formulation with clavulanic acid (a beta-lactamase inhibitor) restores activity against these resistant organisms.
- Amoxicillin + EBV infection = maculopapular rash in ~80-100% of patients (not a true allergy)
- Inhibits cell wall synthesis by binding penicillin-binding proteins (PBPs); bactericidal
- Susceptible to beta-lactamase enzymes; combine with clavulanate for resistant organisms
- First-line for uncomplicated otitis media, community-acquired pneumonia, and group A strep pharyngitis
- No activity against MRSA, Pseudomonas, or atypical bacteria (Mycoplasma, Chlamydia, Legionella)
- Pregnancy Category B; safe during pregnancy and lactation
- Most common adverse effect is diarrhea; risk of C. difficile infection with prolonged use
- Cross-reactivity with cephalosporins in approximately 1-3% of penicillin-allergic patients
Indications
Amoxicillin is indicated for a wide range of bacterial infections caused by susceptible organisms:
Respiratory tract infections
- Acute otitis media
- Acute bacterial sinusitis
- Community-acquired pneumonia
- Acute exacerbations of chronic bronchitis
- Streptococcal pharyngitis
Genitourinary infections
- Uncomplicated urinary tract infections
- Asymptomatic bacteriuria in pregnancy
Gastrointestinal infections
- Helicobacter pylori eradication (triple or quadruple therapy)
- Typhoid fever (caused by Salmonella typhi)
Other infections
- Skin and soft tissue infections
- Dental abscess and prophylaxis for dental procedures
- Endocarditis prophylaxis in high-risk patients
- Lyme disease (early localized or early disseminated)
- Anthrax post-exposure prophylaxis
Amoxicillin is often the first-line agent for uncomplicated infections in children and pregnant women due to its safety profile.
Pharmacokinetics
Absorption: Amoxicillin is well absorbed from the gastrointestinal tract with approximately 70-90% oral bioavailability. Food does not significantly affect absorption. Peak plasma concentrations occur 1-2 hours after oral administration.
Distribution: The drug distributes widely into body tissues and fluids, including middle ear effusions, maxillary sinus secretions, bronchial secretions, and urine. It crosses the placenta and appears in breast milk in small amounts. Penetration into cerebrospinal fluid is poor in the absence of inflammation but increases with meningeal inflammation.
Metabolism: Amoxicillin undergoes minimal hepatic metabolism. Approximately 10-25% is metabolized to inactive metabolites.
Excretion: The drug is primarily eliminated by the kidneys through glomerular filtration and tubular secretion. Approximately 60-70% is excreted unchanged in urine within 6-8 hours. The elimination half-life is approximately 1-1.5 hours in patients with normal renal function but is prolonged in renal impairment, requiring dose adjustment. Hemodialysis removes amoxicillin.
Adverse effects
Amoxicillin is generally well tolerated. Common and serious adverse effects include:
Common adverse effects
- Gastrointestinal: Diarrhea (most common), nausea, vomiting, abdominal pain
- Dermatologic: Maculopapular rash (5-10% of patients)
- Genitourinary: Vaginal candidiasis
Serious adverse effects
- Hypersensitivity reactions: Urticaria, angioedema, anaphylaxis (cross-reactivity with other beta-lactams)
- Stevens-Johnson syndrome and toxic epidermal necrolysis: Rare but life-threatening
- Clostridioides difficile-associated diarrhea: Risk increases with duration of therapy
- Drug reaction with eosinophilia and systemic symptoms (DRESS): Rare multi-organ hypersensitivity
- Crystalluria: Rare, associated with high doses and dehydration
Classic exam association
The amoxicillin rash in infectious mononucleosis is a high-yield concept. When amoxicillin is given to patients with Epstein-Barr virus (EBV) infection, approximately 80-100% develop a characteristic non-allergic maculopapular rash 5-10 days after starting therapy. This is not a true penicillin allergy and does not contraindicate future penicillin use. The mechanism is believed to involve immune complex formation between EBV antigens, amoxicillin, and antibodies.
Hematologic effects
- Eosinophilia
- Reversible thrombocytopenia or leukopenia (rare)
Hepatic effects
- Transient elevation of liver enzymes
- Cholestatic jaundice (more common with amoxicillin-clavulanate)
Contraindications and warnings
Absolute contraindications:
- History of serious hypersensitivity reaction (anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis) to amoxicillin or other beta-lactam antibiotics
- History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin-clavulanate (for combination products)
Warnings and precautions:
Hypersensitivity
Serious and occasionally fatal hypersensitivity reactions can occur. Before initiating therapy, inquire about previous allergic reactions to penicillins, cephalosporins, or other beta-lactams. Cross-reactivity between penicillins and cephalosporins occurs in approximately 1-3% of patients with documented penicillin allergy. However, patients reporting vague or remote penicillin allergy can often safely receive amoxicillin after appropriate evaluation.
Renal impairment
Dose adjustment is required in patients with creatinine clearance less than 30 mL/min to prevent drug accumulation and crystalluria.
Infectious mononucleosis
Avoid amoxicillin in patients with suspected or confirmed infectious mononucleosis due to high incidence of rash.
Superinfection
Prolonged use may result in overgrowth of non-susceptible organisms, including fungi and Clostridioides difficile.
Pregnancy and lactation
Amoxicillin is Pregnancy Category B (FDA historical classification). It crosses the placenta but is considered safe during pregnancy with no evidence of teratogenicity. It is one of the preferred antibiotics for treating infections in pregnant women. Small amounts appear in breast milk but are generally considered compatible with breastfeeding, though infants should be monitored for diarrhea, candidiasis, and allergic reactions.
Drug interactions
Oral contraceptives
Current evidence does not support that amoxicillin significantly reduces the effectiveness of combined oral contraceptives. Unlike enzyme-inducing antibiotics such as rifampin, broad-spectrum antibiotics like amoxicillin do not require additional barrier contraception. This recommendation aligns with WHO and ACOG guidelines.
Probenecid
Probenecid decreases renal tubular secretion of amoxicillin, increasing serum concentrations and prolonging half-life. This interaction was historically used therapeutically but is rarely utilized now. It may be relevant in overdose or toxicity scenarios.
Allopurinol
Concurrent use increases the incidence of amoxicillin-associated rash (not related to allergy mechanism).
Methotrexate
Penicillins can reduce renal clearance of methotrexate, leading to increased serum concentrations and potential toxicity. Monitor methotrexate levels closely.
Warfarin
Amoxicillin may potentiate the anticoagulant effect of warfarin by eliminating vitamin K-producing gut bacteria. Monitor INR more frequently during and after antibiotic therapy.
Live vaccines
Antibiotics may reduce the effectiveness of live bacterial vaccines (e.g., oral typhoid vaccine, BCG). Avoid concurrent administration.
Laboratory interactions
Amoxicillin can cause false-positive results in urine glucose testing using copper reduction methods (e.g., Benedict's solution, Fehling's solution) but not glucose oxidase methods. It may also interfere with some direct Coombs tests, producing false-positive results.
Clinical pearls
- Spectrum: Amoxicillin has excellent activity against Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus, Listeria monocytogenes, and non-beta-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis. It has moderate activity against Escherichia coli, Proteus mirabilis, and Salmonella species.
- First-line therapy: Amoxicillin remains first-line for uncomplicated acute otitis media in children and community-acquired pneumonia in outpatients without risk factors for drug-resistant S. pneumoniae. High-dose amoxicillin (80-90 mg/kg/day in children) is used when resistance is suspected.
- Rash differentiation: The non-allergic maculopapular rash in EBV infection appears 5-10 days after starting amoxicillin and is confluent, beginning on the trunk. True allergic rashes typically appear within 72 hours and are urticarial. The EBV-related rash does not contraindicate future penicillin use.
- Combination with clavulanate: Amoxicillin-clavulanate (co-amoxiclav) extends coverage to beta-lactamase-producing organisms including S. aureus, H. influenzae, M. catarrhalis, E. coli, and anaerobes. It is preferred for complicated infections, human and animal bites, and chronic sinusitis.
- Dental prophylaxis: Amoxicillin is the drug of choice for endocarditis prophylaxis before dental procedures in high-risk patients (e.g., prosthetic heart valves, previous endocarditis).
- Resistance patterns: Resistance is increasing globally, particularly among E. coli urinary isolates (20-40% in many regions) and H. influenzae respiratory isolates. Always consider local resistance patterns and culture results when choosing empiric therapy.
- Penetration: Unlike many penicillins, amoxicillin achieves therapeutic concentrations in middle ear fluid, making it ideal for otitis media.
- Cost-effectiveness: Amoxicillin is inexpensive and widely available, making it a cost-effective choice for community-acquired infections when susceptibility is expected.
- MRSA coverage: Amoxicillin has NO activity against methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. Consider alternative agents when these organisms are suspected.
- Streptococcal pharyngitis: While penicillin V is often preferred for group A streptococcal pharyngitis due to narrower spectrum, amoxicillin is equally effective and offers once-daily dosing options, improving adherence.
AMOXICILLIN for coverage: A = Anaerobes (mouth), M = Moraxella, O = Otitis media bugs, X = eXcellent Strep coverage, I = Ineffective against MRSA/Pseudomonas, C = Clavulanate adds beta-lactamase resistance, I = Inhibits cell wall, L = Listeria, L = Lyme disease, I = Inactivated by beta-lactamase alone, N = No atypical coverage
Practice questions
1. A 7-year-old girl is brought to the clinic with 3 days of fever, sore throat, and fatigue. On examination, she has tonsillar enlargement with exudates, posterior cervical lymphadenopathy, and splenomegaly. A rapid strep test is negative. The physician prescribes amoxicillin. Three days later, the patient returns with a diffuse maculopapular rash covering her trunk and extremities. Which of the following is the most likely diagnosis?
2. A 32-year-old woman presents with dysuria and urinary frequency. Urinalysis shows pyuria and bacteriuria. Urine culture grows Escherichia coli resistant to amoxicillin but sensitive to amoxicillin-clavulanate. Which of the following best explains the resistance pattern?
3. A 45-year-old man with a history of rheumatic heart disease with mitral valve replacement is scheduled for a dental extraction. Which of the following is the most appropriate prophylactic regimen?
Frequently asked questions
How does amoxicillin work?
Amoxicillin works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) in the bacterial cell wall, preventing cross-linking of peptidoglycan chains. This causes the cell wall to weaken, leading to osmotic lysis and bacterial cell death. It is bactericidal and most effective against actively dividing bacteria.
What are the side effects of amoxicillin?
The most common side effect of amoxicillin is diarrhea, occurring in 5-10% of patients. Other frequent effects include nausea, vomiting, and maculopapular rash. Serious but rare side effects include anaphylaxis, Stevens-Johnson syndrome, Clostridioides difficile infection, and drug reaction with eosinophilia and systemic symptoms (DRESS). A characteristic non-allergic rash occurs in 80-100% of patients with infectious mononucleosis who receive amoxicillin.
Can I take amoxicillin if I'm allergic to penicillin?
No, amoxicillin is a penicillin-type antibiotic and should not be taken if you have a true penicillin allergy. However, many patients who report penicillin allergy have vague or remote reactions that may not represent true allergy. If you have a history of anaphylaxis, severe rash, or other serious reaction to penicillin, avoid amoxicillin. Patients with documented penicillin allergy have approximately 1-3% risk of cross-reactivity with cephalosporins.
Amoxicillin vs amoxicillin-clavulanate — what is the difference?
Amoxicillin alone is susceptible to destruction by beta-lactamase enzymes produced by resistant bacteria. Amoxicillin-clavulanate (co-amoxiclav) combines amoxicillin with clavulanic acid, a beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation. This combination extends coverage to beta-lactamase-producing organisms including Staphylococcus aureus, many Haemophilus influenzae and Moraxella strains, Escherichia coli, and anaerobes. Amoxicillin-clavulanate is preferred for complicated infections, animal bites, and when resistance is likely.
Is amoxicillin safe during pregnancy?
Yes, amoxicillin is considered safe during pregnancy and is classified as Pregnancy Category B. It crosses the placenta but extensive human data show no evidence of teratogenicity or fetal harm. Amoxicillin is one of the preferred antibiotics for treating bacterial infections during pregnancy, including urinary tract infections, respiratory infections, and asymptomatic bacteriuria. It also appears in breast milk in small amounts but is generally compatible with breastfeeding.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: J01CA04
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.